Overview
Compare with WEWARDS, INC., TANCHENG GROUP CO., LTD. or Mitesco, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Transuite Technology And Consulting brought in 98% of the revenue TRANSUITE.ORG INC. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Transuite Technology And Consulting | $0 | $115.0K |
| Solan Shenzhen Online medical Education | $0 | $2.8K |
Regions
United States brought in 98% of the revenue TRANSUITE.ORG INC. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $0 | $115.0K |
| China | $0 | $2.8K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue0¢$256
- Other costs88¢$101.3K
- Interest12¢$13.4K
Out of $115.0K in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $117.8K | $0 |
| Cost of sales | $256 | $0 |
| Gross Profit | $117.5K | $0 |
| General and administrative expenses | $36.3K | $11.6K |
| Professional fees (including stock-based compensation of $22,310,560 and $0 for year ended December 31, 2025 and 2024, respectively) | $22.5M | $344.3K |
| Professional fees - related party (including stock-based compensation of $10,110 and $0 for year ended December 31, 2025 and 2024, respectively) | $10.1K | $0 |
| Amortization | $12.9K | $13.1K |
| Impairment loss on goodwill | $14.7M | $0 |
| Impairment loss on intangible assets | $27.6K | $0 |
| Total operating expenses | $37.3M | $369.0K |
| Net loss from operations | -$37.2M | -$369.0K |
| Interest expense | -$13.4K | -$5.9K |
| Gain from debt settlement | $16.7K | $0 |
| Write off of cash | -$22 | $0 |
| Other expense | -$2.2K | $0 |
| Other income | $156 | $0 |
| Total other income (expense) | $1.2K | -$5.9K |
| Net loss before taxes | -$37.2M | -$374.9K |
| Provision for income taxes | $0 | $0 |
| Net loss | -$37.2M | -$374.9K |
| Less: Net loss attributable to non-controlling interest | -$3.4K | -$6.1K |
| Net loss attributable to Transuite.Org. Inc. | -$37.2M | -$368.8K |
| Net loss | -$37.2M | -$374.9K |
| Foreign currency adjustment | $2.4K | $0 |
| Total comprehensive loss | -$37.2M | -$374.9K |
| Less: Comprehensive loss (income) attributable to non-controlling interests | -$3.1K | $0 |
| Net comprehensive loss attributed to stockholders of Transuite.Org. Inc. | -$37.2M | -$374.9K |
| Net Loss Per Common Share - Basic and Diluted | -$1.52 | -$0.09 |
| Weighted Average Common Shares Outstanding | 24.4M shares | 4.0M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2025-11-30 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $3.7K | $0 | ||
| Fund held in trust | $0 | $16.1K | ||
| Accounts receivable | $19.3K | $0 | ||
| Other receivable | $14.9K | $0 | ||
| Prepaid expense | $18.8K | $0 | ||
| Due from related party | $8.9K | $15.0K | ||
| Deferred share issuance cost | $254.8K | $0 | ||
| Total Current Assets | $320.3K | $31.1K | ||
| Property and Equipment | $17.2K | $0 | ||
| Intangible assets, net | $0 | $40.5K | $53.6K | |
| Total Assets | $337.5K | $71.6K | ||
| Accounts payable and accrued liabilities | $109.3K | $66.4K | ||
| Accrued interest | $0 | $16.7K | $3.3K | |
| Due to related party | $11.7K | $2.2K | ||
| Convertible note | $0 | $153.5K | ||
| Stock payable | $688.9K | $0 | ||
| Total Current Liabilities | $809.9K | $225.3K | ||
| Loan payable | $0 | $148.4K | ||
| Total Liabilities | $809.9K | $373.7K | ||
| Common Stock: $0.001 par value, 75,000,000 shares authorized, 61,254,427 shares and 4,046,760 shares issued and outstanding, respectively | $61.3K | $4.0K | ||
| Additional paid-in capital | $46.9M | $143.8K | ||
| Accumulated deficit | -$37.6M | -$458.9K | ||
| Accumulated other comprehensive income | $2.4K | $0 | ||
| Less: Deferred compensation (including $34,890 and $0 of deferred compensation to related party as December 31, 2025 and 2024, respectively) | -$9.9M | $0 | ||
| Total equity (deficit) attributed to Transuite.Org. Inc. | -$485.1K | -$311.0K | ||
| Non-controlling interest | $12.7K | $8.9K | ||
| Total Stockholders' Deficit | -$472.4K | -$302.1K | -$49.5K | |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $337.5K | $71.6K | ||
| Common stock par value | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 75.0M shares | 75.0M shares | ||
| Common Stock Shares Issued | 61.3M shares | 4.0M shares | ||
| Net of deferred compensation to related party | $34.9K | $0 | ||
| Common Stock Shares Outstanding | 2.1M shares | 4.0M shares |
| Period ending | 2025-12-31 | 2025-11-30 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $3.7K | $0 | ||
| Fund held in trust | $0 | $16.1K | ||
| Accounts receivable | $19.3K | $0 | ||
| Other receivable | $14.9K | $0 | ||
| Prepaid expense | $18.8K | $0 | ||
| Due from related party | $8.9K | $15.0K | ||
| Deferred share issuance cost | $254.8K | $0 | ||
| Total Current Assets | $320.3K | $31.1K | ||
| Property and Equipment | $17.2K | $0 | ||
| Intangible assets, net | $0 | $40.5K | $53.6K | |
| Total Assets | $337.5K | $71.6K | ||
| Accounts payable and accrued liabilities | $109.3K | $66.4K | ||
| Accrued interest | $0 | $16.7K | $3.3K | |
| Due to related party | $11.7K | $2.2K | ||
| Convertible note | $0 | $153.5K | ||
| Stock payable | $688.9K | $0 | ||
| Total Current Liabilities | $809.9K | $225.3K | ||
| Loan payable | $0 | $148.4K | ||
| Total Liabilities | $809.9K | $373.7K | ||
| Common Stock: $0.001 par value, 75,000,000 shares authorized, 61,254,427 shares and 4,046,760 shares issued and outstanding, respectively | $61.3K | $4.0K | ||
| Additional paid-in capital | $46.9M | $143.8K | ||
| Accumulated deficit | -$37.6M | -$458.9K | ||
| Accumulated other comprehensive income | $2.4K | $0 | ||
| Less: Deferred compensation (including $34,890 and $0 of deferred compensation to related party as December 31, 2025 and 2024, respectively) | -$9.9M | $0 | ||
| Total equity (deficit) attributed to Transuite.Org. Inc. | -$485.1K | -$311.0K | ||
| Non-controlling interest | $12.7K | $8.9K | ||
| Total Stockholders' Deficit | -$472.4K | -$302.1K | -$49.5K | |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $337.5K | $71.6K | ||
| Common stock par value | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 75.0M shares | 75.0M shares | ||
| Common Stock Shares Issued | 61.3M shares | 4.0M shares | ||
| Net of deferred compensation to related party | $34.9K | $0 | ||
| Common Stock Shares Outstanding | 2.1M shares | 4.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$37.2M | -$374.9K |
| Amortization | $12.9K | $13.1K |
| Imputed interest | $0 | $2.6K |
| Impairment loss on goodwill | $14.7M | $0 |
| Impairment loss on intangible assets | $27.6K | $0 |
| Issuance of common stock to non-affiliates for services | $22.3M | $0 |
| Issuance of common stock to related party for services | $10.1K | $0 |
| Gain on loan settlement | -$16.7K | $0 |
| Other receivable | -$11.9K | $0 |
| Prepaid expense | -$10.9K | $112.5K |
| Deferred Share Issuance Cost | -$5.0K | $0 |
| Accounts payable and accrued liabilities | $72.4K | $62.9K |
| Accrued Interest | $13.4K | $3.3K |
| Net Cash Used in Operating Activities | -$69.3K | -$180.5K |
| Net funds from acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd. | $1.5K | $0 |
| Net funds from acquisition of Goldfinch-Chong (Fuzhou) Technology Co., Ltd. | $621 | $0 |
| Net funds from acquisition of SolanAI Global Ltd. HK | $1.3K | $0 |
| Net Cash Provided by Investing Activities | $3.4K | $0 |
| Proceeds from loans | $64.7K | $183.7K |
| Repayment of loans | -$5.0K | $0 |
| Advancement from related party | $2.0K | $0 |
| Proceeds from loan payable - related party | $25.1K | $2.2K |
| Repayment of loan payable - related party | -$36.2K | $0 |
| Net Cash Provided by Financing Activities | $50.7K | $185.8K |
| Effect of exchange rate changes on cash | $2.8K | $0 |
| Net Change in Cash and Cash Equivalents | -$12.4K | $5.3K |
| Cash at bank | $3.7K | $0 |
| Funds held in trust | $0 | $16.1K |
| Closing cash | $3.7K | $16.1K |
| Cash paid for interest | $0 | $0 |
| Cash paid for taxes | $0 | $0 |
| Forgiveness of loan payable to related party | $0 | $104.7K |
| Issuance of common stock as commitment shares | $249.8K | $0 |
| Issuance of common stock to non-affiliates for services | $22.3M | $0 |
| Issuance of common stock to related party for services | $10.1K | $0 |
| Issuance of common stock for debt settlement | $59.7K | $0 |
| Stock payable for debt settlement | $188.9K | $0 |
| Conversion of convertible notes payable | $153.5K | $0 |
| Issuance of common stock for acquisition of Goldfinch Group Holdings Ltd. BVI | $15.0K | $0 |
| Issuance of common stock for acquisition of SolanAI Global Ltd. | $12.5M | $0 |
| Issuance of common stock for acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd. | $1.7M | $0 |
No quarter-by-quarter statement was filed.
What it owns
What TRANSUITE.ORG INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Machinery and equipment | $17.2K3 Dec 31, 2025 | ||
| Property and equipment, before depreciation | $17.2K3 Dec 31, 2025 | $03 Dec 31, 2024 | |
| Property and equipment, net | $17.2K3 Dec 31, 2025 | $40.5K3 Dec 31, 2024 | −57.7% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated amortization | -$24.0K10 Dec 31, 2024 | -$9.8K10 Nov 30, 2023 | −144.0% |
| Finite-lived intangibles, net | $03 Dec 31, 2025 | $40.5K3 Dec 31, 2024 | −100.0% |
Properties, in its own words
Our executive and administrative office is located at 706, Tower 4, Excellence Century Center, 2030 Jintian Road, Futian District, Shenzhen 518126, China. The space is adequate for our needs.
Item 2 of the 10-K filed May 22, 2026.11
Leadership
Who has led TRANSUITE.ORG INC., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerMengqing Fan Feb 25, 2026 to now12
- Chief financial officerHailiang Li Feb 25, 2026 to now13
Board members and other officers (3)
- Board memberMengqing Fan Feb 25, 2026 to now12
- Board memberShaoli Jiang Feb 25, 2026 to now14
- Board memberKairui Yu Feb 26, 2026 to now15
Timeline
- Sep 9, 20268-K Entered a material agreement; Executive or director change; Regulation FD disclosure16
- Jun 30, 20268-K Regulation FD disclosure17
- Apr 15, 20268-K Bylaws or fiscal year changed; Other events18
- Mar 13, 20268-K Entered a material agreement; Other events19
- Feb 25, 2026New chief executive Mengqing Fan becomes CEO12
- Feb 23, 20268-K Entered a material agreement20
- Feb 12, 20268-K Executive or director change21
- Jan 8, 20268-K Executive or director change22
- Jan 7, 20268-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares23
- Dec 16, 20258-K Executive or director change24
- Oct 14, 20258-K Executive or director change; Shareholder vote25
- Oct 10, 20258-K Executive or director change26
- Oct 9, 20258-K Change in control; Executive or director change27
Filings
72 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 30 major events, 5 insider forms, 15 other. The latest 20:
- Sep 9, 20268-K EDGAR
- Aug 13, 202610-Q EDGAR
- Jun 30, 20268-K EDGAR
- Jun 16, 202610-Q EDGAR
- May 22, 202610-K EDGAR
- May 18, 2026NT 10-Q EDGAR
- Apr 15, 20268-K EDGAR
- Mar 30, 2026NT 10-K EDGAR
- Mar 13, 20268-K EDGAR
- Mar 10, 2026DEF 14C EDGAR
- Feb 27, 2026PRE 14C EDGAR
- Feb 26, 20263 PRIMARY DOCUMENT EDGAR
- Feb 26, 20263 PRIMARY DOCUMENT EDGAR
- Feb 25, 20263 PRIMARY DOCUMENT EDGAR
- Feb 25, 20263 PRIMARY DOCUMENT EDGAR
- Feb 25, 20263 PRIMARY DOCUMENT EDGAR
- Feb 23, 20268-K EDGAR
- Feb 12, 20268-K EDGAR
- Jan 8, 20268-K EDGAR
- Jan 7, 20268-K EDGAR
The 72 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How TRANSUITE.ORG INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTRANSUITE.ORG INC.1
- CIK0001758699
- Employer ID (EIN)30-112958111
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company11
- Incorporated inNevada11
- Fiscal year endsDecember 311
- Industry code (SIC)7370 Services-Computer Programming, Data Processing, Etc.1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address732 S 6Th St # 4304, Las Vegas, NV 891011
- Phone70283396021
- Shares outstanding77,349,992 as of Aug 6, 20269
- Public float$30.8M as of Jun 30, 202511
- AuditorJP CENTURION & PARTNERS PLT, Kuala Lumpur, Malaysia PCAOB ID 6723; no auditor attestation of internal control over financial reporting11
- On EDGAR sinceApr 12, 20211
- Filings82 in all: 8-K (29), 10-Q (14), 10-K (5), 3 (5), S-1/A (5), UPLOAD (5), NT 10-K (4), NT 10-Q (4)1
All 19 form types
10-K/A (1), 10-KT (1), 10-Q/A (1), 8-A12G (1), 8-K/A (1), CORRESP (1), DEF 14C (1), EFFECT (1), PRE 14C (1), S-1 (1), S-8 (1)
- Latest filingsAnnual report (10-K) May 22, 2026
Quarterly report (10-Q) Aug 13, 2026
Latest 8-K (8-K) Sep 9, 2026
Risk factors and legal proceedings
Legal proceedings
We know of no legal proceedings to which we are a party or to which any of our property is the subject which are pending, threatened or contemplated or any unsatisfied judgments against us.
The opening of Item 3, Legal Proceedings.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARHailiang Li, Chief financial officer
- 14SEC EDGARShaoli Jiang, Board member
- 15SEC EDGARKairui Yu, Board member
- 16
- 17SEC EDGARRegulation FD disclosure
- 18
- 19
- 20SEC EDGAREntered a material agreement
- 21SEC EDGARExecutive or director change
- 22SEC EDGARExecutive or director change
- 23
- 24SEC EDGARExecutive or director change
- 25
- 26SEC EDGARExecutive or director change
- 27